Grail passes early test in quest to find cancer in blood

CHICAGO, June 3 (Reuters) - An early stage trial of an ultra-sensitive "liquid biopsy" that scans blood samples for traces of cancer DNA showed it was able to pick up at least one cancer mutation in most of the patients with advanced cancers that were studied.